¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇÑ°í°üÀýÇÐȸ iTHA ½ÉÆ÷Áö¿ò(µÎ¹ø° ³¯) : 2022-07-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇÑ°í°üÀýÇÐȸ iTHA ½ÉÆ÷Áö¿ò(µÎ¹ø° ³¯) : 2022-07-16
±³À°ÀÏÀÚ : 2022-07-16
±³À°Àå¼Ò : Ãáõ º£¾î½ºÈ£ÅÚ ¼Ò¾çȦ  
±³À°ÁÖÁ¦ : 2022³â ´ëÇÑ°í°üÀýÇÐȸ iTHA ½ÉÆ÷Áö¿ò(µÎ¹ø° ³¯)
ÁÖÃÖ±â°ü : ´ëÇÑ°í°üÀýÇÐȸ
´ã´çÀÚ : ±è¼Ò¿¬
¿¬¶ôó : 02-451-9333  
À̸ÞÀÏ : khs202223@naver.com      
±³À°Á¾·ù : Á¤Çü¿Ü°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : °­¿øµµ
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í ÇöÀåµî·Ï, »çÀüµî·Ï ¸ðµÎ °¡´ÉÇÕ´Ï´Ù.      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 08:30~08:40 Vancouver type B1 Fx: Osteosysthesis or Stem revision (considering stem type/fracture pattern/use of allograft)  Á¶¸í·¡(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 08:40~08:50 Vancouver type B2 Fx: Is stem revision always necessary for Vancouver B2 Periprosthetic fractures?  Çѽ¹ü(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 08:50~09:00 Periprosthetic insufficiency femoral fracture: When is surgery necessary? And how?  ¼ÛÁÖÇö(°¡Å縯ÀÇ´ë) 
Åä·Ð 07-16 ¼Ò¾çȦ 09:00~09:15 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 09:15~09:25 Case 1 (Misdiagnosis of Vancouver type B2 fracture as B1, case 1)  ½Å¿øö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 09:25~09:35 Case 2 (Misdiagnosis of Vancouver type B2 fracture as B1, case 2)  À±º´È£(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 09:35~09:45 Case 3 (Vancouver type B1 Fx, especially transverse type, fixation only)  À̼¼¿ø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 09:45~09:55 Case 4 (periprosthetic acetabular fractures around a pre-existing THA)  ±èÇöÁØ(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 09:55~10:05 Case 5 (Periprosthetic atypical femoral fracture)  Á¤È¸Á¤(¿¬¼¼¿øÁÖÀÇ´ë) 
Åä·Ð 07-16 ¼Ò¾çȦ 10:05~10:15 Panel Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ07-16 ¼Ò¾çȦ 10:15~10:35 È޽Ġ () 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 10:35~10:45 Acute PJI after THA (one stage exchange): Retention of components or Exchange of implants  ¿ÀÇöö(±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 10:45~10:55 Late PJI after THA: one stage exchange or two stage exchange (including tips for anti loaded cement spacer)  Á¤¿µ·ü(±¤Áֱ⵶º´¿ø) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 10:55~11:05 Culture negative PJI: How do you manage  ÀÌ»ó¼ö(ÇѸ²ÀÇ´ë) 
Åä·Ð 07-16 ¼Ò¾çȦ 11:05~11:20 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 11:20~11:30 Case I (PJI after arthroplasty)  ³ëÀçÈÖ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 11:30~11:40 Case 2 (Acute PJI after THA)  È²Á¤¸ð(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 11:40~11:50 Case 3 (Late PJI after THA 1)  º¯¼ºÀº(Â÷ÀÇ´ë) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 11:50~12:00 Case 4 (Late PJI after THA 2)  À±ÇÊȯ(¼­¿ï³ª¿ìº´¿ø) 
±³À°½Ã°£ 07-16 ¼Ò¾çȦ 12:00~12:10 Case 5 (Culture positive after total revision of aseptic loosening or Culture negative after revision of septic loosening)  ±èÀ̼®(ÇѾçÀÇ´ë) 
Åä·Ð 07-16 ¼Ò¾çȦ 12:10~12:20 Panel Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇÑ°í°üÀýÇÐȸ iTHA ½ÉÆ÷Áö¿ò(µÎ¹ø° ³¯) : 2022-07-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Àü³²´ëÇб³º´¿ø(½ÅÀåÀÌ½Ä 700·Ê, °£ÀÌ½Ä 100·Ê ±â³ä)¡¤´ëÇÑÀ̽ÄÇÐȸ À̽ĽÉÆ÷Áö¾ö : 2022-07-16
´ÙÀ½±Û ´ë±¸°¡Å縯´ëÇк´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Symposium : 2022-07-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 6 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 8 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 114 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 21 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 79 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 13 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 10 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 8 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 28 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 5 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 10 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 2 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 11 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 9 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 12 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷